October 2018 Cochrane Neonatal Webinar: Diagnostic Test Accuracy Reviews in Neonatal Medicine

Cochrane Neonatal Web Seminar
Supported by:

Diagnostic Test Accuracy Reviews in Neonatal Medicine
October 22, 2018
12:00 pm Eastern Daylight Time

The Cochrane Neonatal Review Group is pleased to announce the 22nd  in a series of sessions focused on specific Cochrane Reviews and the evidence that they provide for practice.
 
We will present a web seminar entitled: “Diagnostic Test Accuracy Reviews in Neonatal Medicine.”   The webinar will be held on October 22, 2018 at 12:00 Eastern Daylight Time.
 
The goal of this session is for participants to be able to identify the underlying principles of diagnostic test accuracy reviews in neonatal medicine and to demonstrate their understanding of DTA review findings. Participants will also be able to transfer their understanding of the findings of DTA reviews into clinical decision scenarios. We will be highlighting a review of “Molecular assays for the diagnosis of sepsis in neonates,” as an example DTA review.

Dr. Gautham Suresh and Dr. Mohan Pammi will be our guest discussants.
 
The webinar is available free to all neonatal physicians, practitioners, trainees, and nurses.

In support of improving patient care, this activity has been planned and implemented by The Robert Larner College of Medicine at The University of Vermont and Cochrane Neonatal.  The University of Vermont is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Vermont designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
This program has been reviewed and is acceptable for up to 1 Nursing Contact Hours.
We hope that this will be an exciting format for discussion of how these interventions can improve neonatal care.

To register for the web seminar, please complete this survey: https://www.surveymonkey.com/r/XJDWK25
 
Questions, email: Colleen Ovelman, colleen.ovelman@uvm.edu

Previously recorded Cochrane Neonatal Seminars can be viewed on our website.

***********************************************************************************************************

LOGIN DETAILS:

Topic:  Cochrane Neonatal Web Seminar: DTA Review of Molecular assays for diagnosing sepsis

Date and Time:  Monday, October 22, 2018 12:00 pm, Eastern Daylight Time (New York, GMT-04:00)
Event number:  642 089 895
Event password:  Cochrane
Event address for attendees:  https://vtoxford.webex.com/vtoxford/onstage/g.php?MTID=e0827d6e5c1d3eb28377ff90140de88a6

If the link doesn’t work for you, go to https://vtoxford.webex.com and enter the Event number:  642 089 895

-------------------------------------------------------

Log in using the link above and follow the instructions on your screen to connect to the conference audio. 

Turn up the volume on your computer and speakers to a comfortable level.

You can also join using the WebEx app on your tablet or smartphone by entering the Event number and password.

-------------------------------------------------------

We encourage you to join the web conference so that you can ask questions of the faculty via text chat.

If you cannot join the web conference, you can listen to the conference audio using the information below.

-------------------------------------------------------
Call-in toll-free number (US/Canada): 1-877-668-4493
Call-in toll number (US/Canada): 1-650-479-3208
Toll-free dialing restrictions: https://www.webex.com/pdf/tollfree_restrictions.pdf
Access code: 642 089 895

https://www.webex.com

IMPORTANT NOTICE: This Webex service includes a feature that allows audio and any documents and other materials exchanged or viewed during the session to be recorded. You should inform all meeting attendees prior to recording if you intend to record the meeting. Please note that any such recordings may be subject to discovery in the event of litigation.